title: Endolymphatic sac tumors in von Hippel-Lindau disease: report of three cases.
abstract: OBJECTIVE
  To illustrate the diagnostic and pathophysiologic issues of endolymphatic sac tumors (ELSTs) and its clinical association with von Hippel-Lindau (VHL) disease and to demonstrate the interest of genetic testing in such cases.
  
  
  METHODS
  Retrospective analysis of 3 cases of ELST with VHL in 3 different clinical and prognostic situations.
  
  
  RESULTS
  The first case was diagnosed on the concomitant finding of a central nervous system lesion. The familial genetic testing revealed the presence of the VHL mutation in an asymptomatic daughter, which justified regular follow-up. In the second case of known VHL syndromic disease, the pathophysiologic role of the endolymphatic sac was questioned, with vertigo as the initial, unique symptom of ELST. In the third case, a giant hypervascularized ELST, initially diagnosed as jugular paraganglioma, was the unique manifestation of VHL disease. The young age of the patient could explain the absence of other tumors.
  
  
  CONCLUSIONS
  Diagnosis of ELSTs may be difficult especially when the original site of the lesion cannot be clearly identified. Such tumors may be revealed or may develop with VHL disease. On presentation of a lytic, vascularized tumor of the posterior face of the petrous bone, clinicians should systematically search for other manifestations of VHL disease and propose a VHL genetic testing for patients, and relatives in case of a positive test, to detect early asymptomatic other tumors. The type of VHL mutation might predict the aggressiveness.
authors.affiliation: Service d'Otorhinolaryngologie, Hôpital Lariboisière (Assistance Publique-Hôpitaux de Paris), Paris, France.
authors.forename: Corneliu-Mircea
authors.initials: CM
authors.lastname: Codreanu
authors.forename: Michèle
authors.initials: M
authors.lastname: Duet
authors.forename: Charlotte
authors.initials: C
authors.lastname: Hautefort
authors.forename: Michel
authors.initials: M
authors.lastname: Wassef
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Guichard
authors.forename: Sophie
authors.initials: S
authors.lastname: Giraud
authors.forename: Stéphane
authors.initials: S
authors.lastname: Richard
authors.forename: Anne-Paule Gimenez
authors.initials: AP
authors.lastname: Roqueplo
authors.forename: Patrice
authors.initials: P
authors.lastname: Tran Ba Huy
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000473:pathology*; D000293:Adolescent; D000328:Adult; D001301:Audiometry, Pure-Tone; D004428:Ear Neoplasms / Q000235:genetics / Q000473:pathology*; D004712:Endolymphatic Sac / Q000473:pathology*; D005260:Female; D005820:Genetic Testing; D034381:Hearing Loss / Q000235:genetics; D006801:Humans; D008875:Middle Aged; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000235:genetics; D006623:von Hippel-Lindau Disease / Q000235:genetics / Q000473:pathology*
chemical_list: D051794:Von Hippel-Lindau Tumor Suppressor Protein; C497446:VHL protein, human